- Filed
- Aug 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Aug 1, 2025 | 742.06M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$2.35M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.07M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $100K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.77M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.6M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$95.18M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$94.91M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $11.78M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $12.3M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $123.11M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $122.55M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $11.33M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $10.98M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $27.12M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $26.9M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 732.39M sh |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.66M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $7.11K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$3.82M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$3.68M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $923.67K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $4.05M |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.98M |